- Home
- FULC vs MFM Comparison
FULC vs MFM Comparison
Compare FULC & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- MFM
- Stock Information
- Founded
- FULC 2015
- MFM 1986
- Country
- FULC United States
- MFM United States
- Employees
- FULC N/A
- MFM N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- MFM Finance Companies
- Sector
- FULC Health Care
- MFM Finance
- Exchange
- FULC Nasdaq
- MFM Nasdaq
- Market Cap
- FULC 221.5M
- MFM 235.2M
- IPO Year
- FULC 2019
- MFM N/A
- Fundamental
- Price
- FULC $3.25
- MFM $5.53
- Analyst Decision
- FULC Hold
- MFM
- Analyst Count
- FULC 10
- MFM 0
- Target Price
- FULC $7.44
- MFM N/A
- AVG Volume (30 Days)
- FULC 843.4K
- MFM 108.1K
- Earning Date
- FULC 11-13-2024
- MFM 01-01-0001
- Dividend Yield
- FULC N/A
- MFM 4.08%
- EPS Growth
- FULC N/A
- MFM N/A
- EPS
- FULC N/A
- MFM 0.03
- Revenue
- FULC $80,871,000.00
- MFM N/A
- Revenue This Year
- FULC $2,821.96
- MFM N/A
- Revenue Next Year
- FULC N/A
- MFM N/A
- P/E Ratio
- FULC N/A
- MFM $176.67
- Revenue Growth
- FULC 2987.86
- MFM N/A
- 52 Week Low
- FULC $2.86
- MFM $4.37
- 52 Week High
- FULC $13.70
- MFM $5.48
- Technical
- Relative Strength Index (RSI)
- FULC 44.64
- MFM 42.78
- Support Level
- FULC $2.86
- MFM $5.50
- Resistance Level
- FULC $3.94
- MFM $5.61
- Average True Range (ATR)
- FULC 0.23
- MFM 0.04
- MACD
- FULC 0.02
- MFM -0.00
- Stochastic Oscillator
- FULC 36.11
- MFM 25.00
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.